Letters to the Editor
Preference is given to letters commenting on contributions published recently in the JRSM. They should not exceed 400 words and should be typed double-spaced.
Drug safety and the CSM Sir, Professor Goldberg (July 1987 JRSM, p 464) notes that the adverse drug reaction team ofthe Committee on Safety of Medicines (CSM) is keeping reactions to excipients in pharmaceuticals under close scrutiny but that such reactions appear to be infrequent. It seems to me likely that more of them would come to the CSM's attention if reporting of adverse reactions were extended to clinical workers other than medical and dental practitioners, in particular to clinical psychologists.
Throughout the 1980s, an increasing number of clinical psychologists in Britain have been adding dietary and nutritional treatments to their repertoire of therapeutic skills', and many are now in the frontline for observing adverse reactions to the supposedly inert ingredients of the medications their patients are taking and would report their observations if encouraged to do so.
To give but one example'', a few years ago a 40-year-old male epileptic patient was referred to me for advice on his diet after he reported to his psychiatrist his discovery that he felt very much better for having eliminated all artificial food dyes from his diet, that he reacted adversely to re-exposure to these substances, and that despite his best efforts at avoidance he suspected that he was still being exposed to them.
Our suspicions fell upon the one coloured ingestant he was still consuming regularly, viz., his anticonvulsant medication, which was presented as an orange and white capsule. Enquiry to the helpful manufacturer revealed that the preparation contained both tartrazine and erythrosine, substances to which the patient had already determined that he was sensitive. When I suggested to his general practitioner that she change his medication from the dyecontaining proprietary formulation to the equivalent dose of a generic formulation presented as an uncoated white tablet, many of the patient's residual symptoms, including difficulty in concentrating, eczema, myalgia, and pruritis (the latter having frequently been reported as a manifestation of sensitivity to tartrazine 3 -5 ) promptly resolved. He felt so much better that he was able to take up voluntary work and that was the last I saw of him.
Informal discussions with colleagues in other hospitals suggest that my patient is not the only instance of adverse reactions to drug excipients that has come to the attention of psychologists but has not been passed on to the CSM for want ofencouragement. It seems a pity to overlook this additional potential source of observations of what is most probably a more common problem than it is at present credited with being. V There are two distinct pathological types of thoracic disc prolapse -calcified and non-calcified'. The former is a complication of dystrophic calcification in the nucleus pulposus, and the latter is similar to the common lumbar lesions. The spinal distribution for the two types of surgically proven prolapses is quite different. The maximal incidence ofcalcified prolapses is at T9-10 and non-calcifiedones peak at Tll-12. The maximal age incidence for both types is in the fifth decade of life. Bruckner et al. reported on a series of patients whose female to male ratio was 5: 1, whereas with surgically proven prolapses it is 1 : 2. Furthermore, 94.6% of their female patients with benign thoracic pain were less than 30 years of age. On these facts alone, their hypothesis that benign thoracic pain (as described) is based on disc prolapse, is extremely tenuous.
In my experience, benign thoracic pain syndrome is most often seen in young females. Pain and tenderness are rarely confined to one level, and both are usually present over at least two to three segments in the upper to midthoracic region. Tenderness tends to be maximal over the interspinous ligaments and it can be abolished by infiltration with a local anaesthetic. The presence of hyperesthesia on the trunk can readily be accounted for by referred somatic pain, where subtle alterations in cutaneous sensibility are extremely common". The condition readily responds to an exercise programme designed to improve the efficiency of the extensor musculature, and to postural control mechanisms. Perhaps even more important is a positive and reassuring approach to patients who often have long histories of spinal pain, and who have been given neither a positive diagnosis nor any effective treatment. Mobilizing therapy has been reserved for the few patients with limited spinal movements and such patients usually have long histories. No patient in my hands has ever required
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Surgery and, hence, the pathology is unknown. None has ever subsequently been proven to have a thoracic disc prolapse. The clinical features are in keeping with a disorder which is linked with postural insufficiency. At presentation this is often associated with a complex psychophysiological reaction to chronic musculoskeletal pain. Most journal readers would agree that these events set the stage for diagnostic dilemmas, inappropriate investigation (often expensive) and misdirected management. T 
*The authors reply below:
Sir, We thank Professor Taylor for his interest in our paper and his helpful comments. The purpose of our paper was to draw attention to and define a fairly common syndrome whose main feature is chest pain and which has a benign prognosis. Many of these patients are worried about the diagnosis and, as Professor Taylor points out, are subjected to extensive investigations. Our suggestion that the syndrome is due to a thoracic disc lesion is no more than a hypothesis, just as is Professor Taylor's suggestion that it is linked with postural insufficiency. We are carrying out further studies on these patients and hope to present firmer evidence in support of our hypothesis in the near future. FE BRUCKNER S A ALLARD N A MOUSSA
Origin of non-haematogenous synovial lining cells in inflammatory hyperplasia
Sir, Having read the most interesting article by Dr Howat (August 1987 JRSM, p 477), I wonder how the labelled cells were distributed in the deep stroma 24 hours after the injection of tritiated thimidine? Were they scattered more or less evenly or did they form clusters in and around capillaries?
I am inspired to this question by the hypothesis that vascular endothelial cells become the stem cells for fibroblastic cells during repair! and by the fact that vascular hyperplasia is present in rheumatoid arthritis''.
Established chronic arthritis was used as the experimental model in this study. In this situation, the distinct recognition of original clonogenic cells may be hindered by a presence ofthe cells of successive generations still dividing and labelled", J T BERANEK Institut de Cancerologie et d'Immunogenetique Hopital Paul-Brousse, Villejuif, France *Dr Howat replies below:
Sir, My article was a transcript of a short lecture at a Section of Pathology meeting; the data have been published in full elsewhere'.
The main thrust of my work was simply to demonstrate proliferating cells that could account for the thickened synovial lining found in the rheumatoid condition. By its nature, the experimental design could not disclose the nature of the cells involved in the proliferation. However, I can expand upon the cell type and distribution. These cells appeared to be fibroblastic, but one must emphasize that it is all but impossible to identify cells lying underneath a heavy deposit of silver grains produced by the autoradiographic technique. At the shorter time point, the distribution of the cells was random throughout the deep stroma with no preference for perivascular locations. The possibility that the stem cells themselves could be derived from vascular endothelial cells, or some other cell type, that have migrated from the blood vessels early in the condition and have continued to divide, cannot be ruled out by my work. 
